Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation-Reference-Cited by-同舟云学术

Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation

Published:2022-11-01 Issue:4 Volume:8 Page:385-395
ISSN:2364-1754
Container-title:Pulmonary Therapy
language:en
Short-container-title:Pulm Ther

Author:

Sawicki Gregory S.,Konstan Michael W.,McKone Edward F.,Moss Richard B.,Lubarsky Barry,Suthoff Ellison,Millar Stefanie J.,Pasta David J.,Mayer-Hamblett Nicole,Goss Christopher H.,Morgan Wayne J.,Duncan Margaret E.,Yang Yoojung

Funder

Vertex Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Respiratory Care

Link

https://link.springer.com/content/pdf/10.1007/s41030-022-00202-y.pdf

Reference26 articles.

1. Ratjen F, Bell SC, Rowe SM, Goss CH, Quittner AL, Bush A. Cystic fibrosis. Nat Rev Dis Primers. 2015;1:15010.

2. Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020;8(1):65–124.

3. Dugueperoux I, De Braekeleer M. The CFTR 3849+10kbC->T and 2789+5G->A alleles are associated with a mild CF phenotype. Eur Respir J. 2005;25(3):468–73.

4. McKone EF, Goss CH, Aitken ML. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest. 2006;130(5):1441–7.

5. Wagener JS, Millar SJ, Mayer-Hamblett N, Sawicki GS, McKone EF, Goss CH, et al. Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation. J Cyst Fibros. 2018;17(4):503–10.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftor;Journal of Cystic Fibrosis;2024-07